{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:05:41Z","timestamp":1791201941217,"version":"4.2.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"15-16","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["GACR 303\/08\/P137"],"award-info":[{"award-number":["GACR 303\/08\/P137"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.drudis.2008.05.003","type":"journal-article","created":{"date-parts":[[2008,6,24]],"date-time":"2008-06-24T10:56:14Z","timestamp":1214304974000},"page":"716-722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["The value of proteasome inhibition in cancer"],"prefix":"10.1016","volume":"13","author":[{"given":"Boris","family":"Cvek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Dvorak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2008.05.003_bib1","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.cdd.4401702","article-title":"The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle","volume":"12","author":"Hershko","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.drudis.2008.05.003_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2174\/1570180053398406","article-title":"Exploiting the ubiquitin\u2013proteasome pathway for anticancer drug discovery: unanswered questions and future directions","volume":"2","author":"Smith","year":"2005","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.drudis.2008.05.003_bib3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nrd2056","article-title":"Drug discovery in the ubiquitin\u2013proteasome system","volume":"5","author":"Nalepa","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drudis.2008.05.003_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/01.jcp.0000222512.25649.08","article-title":"The status of disulfiram. A half of a century later","volume":"26","author":"Suh","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drudis.2008.05.003_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-0447.1992.tb03317.x","article-title":"Disulfiram therapy \u2013 adverse drug-reactions and interactions","volume":"86","author":"Poulsen","year":"1992","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.drudis.2008.05.003_bib6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1158\/1535-7163.1049.3.9","article-title":"Disulfiram inhibits activating transcription factor\/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic disease","volume":"3","author":"Brar","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drudis.2008.05.003_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(03)01074-2","article-title":"Back to the future with ubiquitin","volume":"116","author":"Pickart","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1074\/jbc.M206279200","article-title":"Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome","volume":"278","author":"Shringarpure","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2008.05.003_bib9","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1128\/MCB.25.9.3483-3491.2005","article-title":"FAT10, a ubiquitin-independent signal for proteasomal degradation","volume":"25","author":"Hipp","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.drudis.2008.05.003_bib10","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.molcel.2007.05.028","article-title":"Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REG-\u03b3-proteasome pathway","volume":"26","author":"Li","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.molcel.2007.05.022","article-title":"Ubiquitin-independent degradation of cell-cycle inhibitors by the REG-\u03b3 proteasome","volume":"26","author":"Chen","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cell.2004.06.014","article-title":"Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin\u2013proteasome system","volume":"118","author":"Verma","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cell.2006.07.038","article-title":"Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradation","volume":"127","author":"Hanna","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib14","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2006.09.051","article-title":"Ubiquitin chains are remodeled at the proteasome by opposing ubiquitin ligase and deubiquitinating activities","volume":"127","author":"Crosas","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.molcel.2007.06.033","article-title":"Docking of the proteasomal ATPases\u2019 carboxyl termini in the 20S proteasome's \u03b1 ring opens the gate for substrate entry","volume":"27","author":"Smith","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1389203043379774","article-title":"Proteasome function in antigen presentation: immunoproteasome complexes, peptide production, and interactions with viral proteins","volume":"5","author":"Rivett","year":"2004","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.drudis.2008.05.003_bib17","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1121925","article-title":"Protein synthesis upon acute nutrient restriction relies on proteasome function","volume":"310","author":"Vabulas","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.drudis.2008.05.003_bib18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1474-9726.2007.00329.x","article-title":"Aging and regulated protein degradation: who has the UPPer hand?","volume":"6","author":"Vernace","year":"2007","journal-title":"Aging Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.molcel.2006.12.020","article-title":"The proteasome regulates HIV-1 transcription by both proteolytic and nonproteolytic mechanisms","volume":"25","author":"Lassot","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2006.10.002","article-title":"Keeping transcriptional activators under control","volume":"127","author":"Kodadek","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib21","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1126\/science.1141194","article-title":"SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins","volume":"316","author":"Busino","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.drudis.2008.05.003_bib22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1535-6108(04)00120-5","article-title":"The development of proteasome inhibitors as anticancer drugs","volume":"5","author":"Adams","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev.med.57.042905.122625","article-title":"Bortezomib: proteasome inhibition as an effective anticancer therapy","volume":"57","author":"Richardson","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.drudis.2008.05.003_bib24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.drup.2006.11.001","article-title":"The proteasome as a potential target for novel anticancer drugs and chemosensitizers","volume":"9","author":"Landis-Piwowar","year":"2006","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drudis.2008.05.003_bib25","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.bcp.2003.10.031","article-title":"Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells","volume":"67","author":"Daniel","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drudis.2008.05.003_bib26","doi-asserted-by":"crossref","first-page":"10478","DOI":"10.1158\/0008-5472.CAN-06-3017","article-title":"A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts","volume":"66","author":"Milacic","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2008.05.003_bib27","doi-asserted-by":"crossref","first-page":"9258","DOI":"10.1158\/0008-5472.CAN-07-1813","article-title":"Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti-prostate tumor effects","volume":"67","author":"Chen","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2008.05.003_bib28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ccr.2005.10.013","article-title":"A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from bortezomib","volume":"8","author":"Chauhan","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib29","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1158\/0008-5472.CAN-06-4086","article-title":"Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome","volume":"67","author":"Demo","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2008.05.003_bib30","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1021\/cr0502504","article-title":"20S proteasome and its inhibitors: crystallographic knowledge for drug development","volume":"107","author":"Borissenko","year":"2007","journal-title":"Chem. Rev."},{"key":"10.1016\/j.drudis.2008.05.003_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrc1361","article-title":"The proteasome: a suitable antineoplastic target","volume":"4","author":"Adams","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drudis.2008.05.003_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.pharmtox.46.120604.141300","article-title":"The proteasome and proteasome inhibitors in cancer therapy","volume":"46","author":"Voorhees","year":"2006","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.drudis.2008.05.003_bib33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrc1588","article-title":"Nuclear factor-\u03baB inhibitors as sensitizers to anticancer drugs","volume":"5","author":"Nakanishi","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drudis.2008.05.003_bib34","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1128\/MCB.01219-06","article-title":"Upregulation of Twist-1 by NF-\u03baB blocks cytotoxicity induced by chemotherapeutic drugs","volume":"27","author":"Pham","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.drudis.2008.05.003_bib35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2174\/156800905774574075","article-title":"Anti-angiogenic and anti-tumor properties of proteasome inhibitors","volume":"5","author":"Daniel","year":"2005","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.drudis.2008.05.003_bib36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2006.02.016","article-title":"Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer","volume":"124","author":"Karin","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ccr.2007.07.004","article-title":"Frequent engagement of the classical and alternative NF-\u03baB pathways by diverse genetic abnormalities in multiple myeloma","volume":"12","author":"Annunziata","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ccr.2007.07.003","article-title":"Promiscuous mutations activate the noncanonical NF-\u03baB pathway in multiple myeloma","volume":"12","author":"Keats","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm2083","article-title":"Integrating cell-signalling pathways with NF-\u03baB and IKK function","volume":"8","author":"Perkins","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drudis.2008.05.003_bib40","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-\u03baB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2008.05.003_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.molcel.2007.02.019","article-title":"Phosphorylation of CBP by IKK\u03b1 promotes cell growth by switching the binding preference of CBP from p53 to NF-\u03baB","volume":"26","author":"Huang","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib42","doi-asserted-by":"crossref","first-page":"21013","DOI":"10.1074\/jbc.M512908200","article-title":"TLR8-mediated NF-\u03baB and JNK activation are TAK1-independent and MEKK3-dependent","volume":"281","author":"Qin","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2008.05.003_bib43","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1074\/jbc.M609039200","article-title":"Interleukin-1 (IL-1)-induced TAK1-dependent versus MEKK3-dependent NF\u03baB activation pathways bifurcate at IL-1 receptor-associated kinase modification","volume":"282","author":"Yao","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2008.05.003_bib44","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.immuni.2007.05.020","article-title":"Tumor-infiltrating \u03b3\u03b4 T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway","volume":"27","author":"Peng","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.drudis.2008.05.003_bib45","doi-asserted-by":"crossref","first-page":"34538","DOI":"10.1074\/jbc.M504943200","article-title":"Phosphorylation of RelA\/p65 on serine 536 defines an I\u03baB\u03b1-independent NF-\u03baB pathway","volume":"280","author":"Sasaki","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2008.05.003_bib46","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1126\/science.1099962","article-title":"Oscillations in NF-\u03baB signaling control the dynamics of gene expression","volume":"306","author":"Nelson","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.drudis.2008.05.003_bib47","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","article-title":"Missing pieces in the NF-\u03baB puzzle","volume":"109","author":"Gosh","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib48","doi-asserted-by":"crossref","first-page":"26115","DOI":"10.1074\/jbc.M313509200","article-title":"p53 induces NF-\u03baB activation by an I\u03baB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1","volume":"279","author":"Bohuslav","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2008.05.003_bib49","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/35009130","article-title":"Role of NF-\u03baB in p53-mediated programmed cell death","volume":"404","author":"Ryan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2008.05.003_bib50","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1097-2765(04)00131-5","article-title":"Active repression of antiapoptotic gene expression by RelA(p65) NF-\u03baB","volume":"13","author":"Campbell","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib51","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1158\/0008-5472.CAN-04-3494","article-title":"Nuclear factor-\u03baB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-\u03baB-dependent transcription in cancer cells","volume":"65","author":"Ho","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2008.05.003_bib52","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1158\/0008-5472.CAN-05-2234","article-title":"Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-\u03baB transactivation","volume":"66","author":"Campbell","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2008.05.003_bib53","doi-asserted-by":"crossref","first-page":"22118","DOI":"10.1074\/jbc.M601350200","article-title":"Proteasome inhibitors induce death but activate NF-\u03baB on endometrial carcinoma cell lines and primary culture explants","volume":"281","author":"Dolcet","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2008.05.003_bib54","doi-asserted-by":"crossref","first-page":"10326","DOI":"10.1074\/jbc.M412643200","article-title":"A novel NF-\u03baB pathway involving IKK\u03b2 and p65\/Re1A ser-536 phosphorylation results in p53 inhibition in the absence of NF-\u03baB transcriptional activity","volume":"280","author":"Jeong","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2008.05.003_bib55","doi-asserted-by":"crossref","first-page":"11093","DOI":"10.1158\/0008-5472.CAN-07-1576","article-title":"Nuclear factor-\u03baB, an unappreciated tumor suppressor","volume":"67","author":"Chen","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2008.05.003_bib56","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(88)90184-5","article-title":"Randomized, double-blind, placebo-controlled trial of ditiocarb sodium (imuthiol) in human immunodeficiency virus-infection","volume":"2","author":"Lang","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2008.05.003_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/0471725587.ch1","article-title":"Main group dithiocarbamate complexes","volume":"53","author":"Heard","year":"2005","journal-title":"Prog. Inorg. Chem."},{"key":"10.1016\/j.drudis.2008.05.003_bib58","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/0471725587.ch2","article-title":"Transition metal dithiocarbamates: 1978\u20132003","volume":"53","author":"Hogarth","year":"2005","journal-title":"Prog. Inorg. Chem."},{"key":"10.1016\/j.drudis.2008.05.003_bib59","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.2174\/138161207782110390","article-title":"Targeting of nuclear factor-\u03baB and proteasome by dithiocarbamate complexes with metals","volume":"13","author":"Cvek","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.drudis.2008.05.003_bib60","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/365182a0","article-title":"Rapid proteolysis of I\u03baB-\u03b1 is necessary for activation of transcription factor NF-\u03baB","volume":"365","author":"Henkel","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2008.05.003_bib61","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1128\/MCB.15.3.1294","article-title":"In vivo stimulation of I\u03baB phosphorylation is not sufficient to activate NF-\u03baB","volume":"15","author":"Alkalay","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.drudis.2008.05.003_bib62","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1124\/mol.64.5.1076","article-title":"Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram","volume":"64","author":"Shiah","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drudis.2008.05.003_bib63","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.yexcr.2004.04.017","article-title":"Pyrrolidine dithiocarbamate and zinc inhibit proteasome-dependent proteolysis","volume":"298","author":"Kim","year":"2004","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.drudis.2008.05.003_bib64","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1034\/j.1600-0749.2003.00046.x","article-title":"Melanin as a target for melanoma chemotherapy: pro-oxidant effect of oxygen and metals on melanoma viability","volume":"16","author":"Farmer","year":"2003","journal-title":"Pigment Cell Res."},{"key":"10.1016\/j.drudis.2008.05.003_bib65","doi-asserted-by":"crossref","first-page":"R897","DOI":"10.1186\/bcr1322","article-title":"Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells","volume":"7","author":"Daniel","year":"2005","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.drudis.2008.05.003_bib66","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.2741\/1749","article-title":"Inhibition of prostate cancer cellular proteasome activity by a pyrrolidine dithiocarbamate\u2013copper complex is associated with suppression of proliferation and induction of apoptosis","volume":"10","author":"Chen","year":"2005","journal-title":"Front. Biosci."},{"key":"10.1016\/j.drudis.2008.05.003_bib67","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1158\/0008-5472.CAN-06-2126","article-title":"Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity","volume":"66","author":"Chen","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2008.05.003_bib68","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/ijc.21534","article-title":"Inhibition of proteasome activity, nuclear factor-KB translocation and cell survival by the antialcoholism drug disulfiram","volume":"118","author":"Lovborg","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drudis.2008.05.003_bib69","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1093\/emboj\/cdg332","article-title":"Evidence that reactive oxygen species do not mediate NF-\u03baB activation","volume":"22","author":"Hayakawa","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.drudis.2008.05.003_bib70","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0092-8674(03)00722-0","article-title":"COP9 signalosome: a multifunctional regulator of SCF and other cullin-based ubiquitin ligases","volume":"114","author":"Cope","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2008.05.003_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2091-7-1","article-title":"Targeted silencing of Jab1\/Csn5 in human cells downregulates SCF activity through reduction of F-box protein levels","volume":"7","author":"Cope","year":"2006","journal-title":"BMC Biochem."},{"key":"10.1016\/j.drudis.2008.05.003_bib72","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nsmb1191","article-title":"Direct interactions between NEDD8 and ubiquitin E2 conjugating enzymes upregulate cullin-based E3 ligase activity","volume":"14","author":"Sakata","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.drudis.2008.05.003_bib73","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/sj.emboj.7601600","article-title":"CSN controls NF-\u03baB by deubiquitinylation of I\u03baB\u03b1","volume":"26","author":"Schweitzer","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.drudis.2008.05.003_bib74","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1371\/journal.pbio.0040267","article-title":"Structural organization of the 19S proteasome lid: insights from MS of intact complexes","volume":"4","author":"Sharon","year":"2006","journal-title":"PLoS Biol."},{"key":"10.1016\/j.drudis.2008.05.003_bib75","first-page":"113","article-title":"JAMM: a metalloprotease-like zinc site in the proteasome and signalosome","volume":"2","author":"Ambroggio","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1016\/j.drudis.2008.05.003_bib76","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.1075901","article-title":"Role of predicted metalloprotease motif of Jab1\/Csn5 in cleavage of Nedd8 from Cul1","volume":"298","author":"Cope","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.drudis.2008.05.003_bib77","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1126\/science.1075898","article-title":"Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome","volume":"298","author":"Verma","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.drudis.2008.05.003_bib78","doi-asserted-by":"crossref","unstructured":"Cvek, B. et al. (2007) Opposite effects of two zinc(II) dithiocarbamates on NF-\u03baB pathway. Nature Precedings. http:\/\/dx.doi.org\/10.1038\/npre.2007.735.1 (http:\/\/www.precedings.nature.com)","DOI":"10.1038\/npre.2007.735"},{"key":"10.1016\/j.drudis.2008.05.003_bib79","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2008.05.003_bib80","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/jnci\/92.11.898","article-title":"Blockage of drug resistance in vitro by disulfiram, a drug used to treat alcoholism","volume":"92","author":"Loo","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.drudis.2008.05.003_bib81","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1124\/mol.65.3.675","article-title":"The molecular basis of the action of disulfiram as a modulator of the multidrug resistance-linked ATP binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1)","volume":"65","author":"Sauna","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drudis.2008.05.003_bib82","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ijc.10972","article-title":"Disulfiram-mediated inhibition of NF-\u03baB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell","volume":"104","author":"Wang","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drudis.2008.05.003_bib83","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ijc.1565","article-title":"Cu\/Zn superoxide dismutase plays a role in angiogenesis","volume":"97","author":"Marikovsky","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drudis.2008.05.003_bib84","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1016\/S0021-9258(19)52496-6","article-title":"Reexamination of the reaction of diethyldithiocarbamate with the copper of superoxide-dismutase","volume":"256","author":"Cocco","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2008.05.003_bib85","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1158\/1535-7163.MCT-06-0542","article-title":"The JAMM motif of human deubiquitinase Poh1 is essential for cell viability","volume":"6","author":"Gallery","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drudis.2008.05.003_bib86","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/ng1752","article-title":"Genetic regulators of large-scale transcriptional signatures in cancer","volume":"38","author":"Adler","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drudis.2008.05.003_bib87","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1158\/1541-7786.MCR-05-0233","article-title":"The emerging role of the COP9 signalosome in cancer","volume":"3","author":"Richardson","year":"2005","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.drudis.2008.05.003_bib88","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bcp.2006.08.016","article-title":"Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients","volume":"73","author":"Wickstrom","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drudis.2008.05.003_bib89","series-title":"The Structure of Scientific Revolutions","author":"Kuhn","year":"1996"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644608001633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644608001633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:01:35Z","timestamp":1761220895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644608001633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":89,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S1359644608001633"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2008.05.003","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The value of proteasome inhibition in cancer","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2008.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}